America Great Health (AAGH)

OTCMKTS · Delayed Price · Currency is USD

0.0003

0.00 (0.00%)

At close: Oct 9, 2026

Market Cap	6.35M -40.0%
Revenue (ttm)	363.33K -5.1%
Net Income	639.11K
EPS	0.00
Shares Out	21.15B
PE Ratio	10.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,400
Open	0.0003
Previous Close	0.0003
Day's Range	0.0003 - 0.0003
52-Week Range	0.000001 - 0.0006
Beta	-11.52
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 14, 2026

About America Great Health

America Great Health operates as a biotechnology company in the United States. The company focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and re-generational medicine and supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, California. [Read more]

Industry Biotechnology

Sector Healthcare

CEO Mike Wang

Employees 5

Stock Exchange OTCMKTS

Ticker Symbol AAGH

Full Company Profile

Financial Performance

In fiscal year 2025, America Great Health's revenue was $391,743, an increase of 32.94% compared to the previous year's $294,670. Losses were -$719,119, -41.08% less than in 2024.

Financial Statements